UK cost-effectiveness watchdog, NICE, has rejected Eli Lilly's Alimta (pemetrexed) for treating mesothelioma, the local arm of the U.S. company said on Monday. In a statement timed to tie in with the anticipated announcement of the rejection by NICE, Li… more »
Technorati tags: altimaeli lillymesotheliomapemetrexed
Flickr tags: altimaeli lillymesotheliomapemetrexed